170 related articles for article (PubMed ID: 37115381)
1. Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency.
Yu Y; Xu L; Xu T; Yang C; Bu Q; Zhang W; Zhao L; Xu Y; Jiang W
Clin Exp Nephrol; 2023 Aug; 27(8):680-686. PubMed ID: 37115381
[TBL] [Abstract][Full Text] [Related]
2. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
Trinh S; Le AK; Chang ET; Hoang J; Jeong D; Chung M; Lee MH; Wang U; Henry L; Cheung R; Nguyen MH
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):948-956.e1. PubMed ID: 30130625
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of tacrolimus and entecavir combination therapy in the treatment of hepatitis B virus-associated glomerulonephritis: a multi-center, placebo controlled, and single-blind randomized trial.
Xie XF; Xie BY; Zhang WH; Hou JH; Liu DL; Zhang L; Xu LX; Li ZL; Li RZ; Ye ZM
Ann Palliat Med; 2022 May; 11(5):1762-1773. PubMed ID: 35672893
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
Sun LJ; Shan JP; Cui RL; Yuan WJ; Jiang GR
Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.
Wang L; Xie B; Zheng Q; Xu L; Ye Z
Rev Esp Enferm Dig; 2020 Nov; 112(11):843-849. PubMed ID: 33054304
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
7. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study.
Yan Z; Qiao B; Zhang H; Wang Y; Gou W
Medicine (Baltimore); 2018 Aug; 97(31):e11716. PubMed ID: 30075577
[TBL] [Abstract][Full Text] [Related]
10. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
He J; Ning HB; Zeng YL; Li W; Li K; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
[No Abstract] [Full Text] [Related]
11. Hepatitis B-related glomerulonephritis and optimization of treatment.
Liu Y; Shi C; Fan J; Wang B; Li G
Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):113-125. PubMed ID: 31951758
[No Abstract] [Full Text] [Related]
12. Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report.
Kataoka H; Mochizuki T; Akihisa T; Kawasoe K; Kawachi K; Makabe S; Sawada A; Manabe S; Sato M; Amemiya N; Mitobe M; Akanuma T; Ito Y; Inoue T; Suzuki T; Matsui K; Moriyama T; Horita S; Ohara M; Honda K; Nitta K
Medicine (Baltimore); 2019 Jan; 98(2):e14014. PubMed ID: 30633192
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
14. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
Li W; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
[TBL] [Abstract][Full Text] [Related]
15. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study of mixed cryoglobulinemic glomerulonephritis secondary to hepatitis B virus infection.
Li C; Li H; Su W; Wen YB; Ye W; Ye WL; Cai JF; Qin XZ; Li XM; Li XW
BMC Nephrol; 2020 Sep; 21(1):395. PubMed ID: 32928133
[TBL] [Abstract][Full Text] [Related]
17. The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication.
Wang L; Ye Z; Liang H; Zhang B; Xu L; Feng Z; Liu S; Shi W
Am J Transl Res; 2016; 8(3):1593-600. PubMed ID: 27186284
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus
Peng W; Gu H; Jiang C; Liu J; Zhang J; Fu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):194-201. PubMed ID: 35545409
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.
Yuan Y; Iloeje UH; Hay J; Saab S
J Manag Care Pharm; 2008; 14(1):21-33. PubMed ID: 18240879
[TBL] [Abstract][Full Text] [Related]
20. Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma.
Jeon MY; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim SU
J Viral Hepat; 2020 Sep; 27(9):932-940. PubMed ID: 32365240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
